Early and accurate diagnosis of congenital toxoplasmosis

Pediatric Infectious Disease Journal

Volumn 27, Issue 2, 2008, Pages 125-129

  Ciardelli, Laura ^a,d   Meroni, Valeria ^b   Avanzini, Maria Antonietta ^a   Bollani, Lina ^c   Tinelli, Carmine ^d   Garofoli, Francesca ^a   Gasparoni, Antonella ^e   Stronati, Mauro ^c  

^a Research Laboratories (Neonatal Immunology and Paediatric Oncohematology)   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c Neonatal Intensive Care Unit

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e SPEDALI CIVILI   (Italy)

Author keywords

Congenital toxoplasmosis; Diagnosis; T cell immunity

Indexed keywords

GAMMA INTERFERON; PARASITE ANTIGEN;

ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; HUMAN; INTERFERON PRODUCTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; NEWBORN; PRIORITY JOURNAL; T LYMPHOCYTE; TOXOPLASMA GONDII; CELL PROLIFERATION; FEMALE; IMMUNOLOGY; INFANT; MALE; PHYSIOLOGY;

ANTIGENS, PROTOZOAN; CELL PROLIFERATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; T-LYMPHOCYTES; TOXOPLASMOSIS, CONGENITAL;

EID: 40949104038     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181586052     Document Type: Article

References (27)

1. Silveira C, Belfort R Jr, Burnier M Jr, Nussenblatt R. Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol. 1988;106:362-364.
2. Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In: Remington JS, Klein J, Wilson CB, et al, eds. Infectious Diseases of the Fetus and Newborn Infant. 6th ed, Philadelphia, PA: WB Saunders; 2006:947-991.
3. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965-1976.
4. Daffos F, Forestier F, Capella-Pavlovsky M, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Eng J Med. 1988;318:271-275.
5. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital toxo-plasma infection. Pediatrics. 1980;66:767-774.
6. Desmonts G, Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Chartier M. Prenatal diagnosis of congenital toxoplasmosis . Lancet. 1985;1:500-504.
7. Lappalainen M, Hedman K. Serodiagnosis of toxolasmosis. The impact of measurement of IgG avidity. Ann Ist Super Sanità . 2004;40:81-88.
8. Gilbert RE, Thalib L, Tan HK, et al. Screening for congenital toxoplas-mosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen. 2007;14:8-13.
9. Villena I, Chemla C, Aubert D, Foudrinier F, Pinon JM, et al. Groupe toxoplasmose de Reims. Toxoplasmose congénitale: diagnostic bi-ologique neonatal et surveillance. Arch Ped. 2003;10:39-40.
10. Yamamoto JH, Vallochi AL, Silveira C, et al. Discrimination between patients with acquired Toxoplasmosis and congenital Toxoplasmosis on the basis of the immune response to parasite antigens. J Infect Dis. 2000;181:2018-2022.
11. Scorza T, D'Souza S, Laloup M, et al. A GRA1 DNA vaccine primes cytolytic CD8+ T cells to control acute Toxoplasma gondiiinfection. Infect Immun. 2003;71:309-316.
12. Scott P, Trinchieri G. The role of natural killer cells in host parasite interactions. Curr Opin Immunol. 1995;7:34-40.
13. Abou-Bacar A, Pfaff AW, Georges S, et al. Role of NK cells and gamma interferon in transplacental passage of Toxoplasma gondii in a mouse model of primary infection. Infect Immun. 2004;72:1397-1401.
14. Fatoohi AF, Cozon GJN, Wallon M, et al. Cellular immunity to Toxo-plasma gondii in congenitally infected newborns and immunocompetent infected hosts. Eur J Clin Microbiol Infect Dis. 2003;22:181-184.
15. Kahi S, Cozon GJN, Greenland T, Wallon M, Gay-Andrieu F, Peyron F. A rapid flow cytometric method to explore cellular immunity against Toxo-plasma gondii in humans. Clin Diagn Lab Immunol. 1998;5:745-748.
16. Denkers EY, Gazzinelli RT. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev. 1998;11:569-588.
17. Singh SD, Booth CG. Tuberculin-induced lymphocyte proliferation in whole blood: an antigen-specific method for assessing immunosuppressive agents. J Immunol Methods. 2002;260:149-156.
18. Fatoohi AF, Cozon GJN, Gonzalo P, et al. Heterogeneity in cellular and humoral immune responses against Toxoplasma gondiiantigen in humans. Clin Exp Immunol. 2004;136:535-541.
19. Caruso A, Licenziati S, Corulli M, et al. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry. 1997;27:71-76.
20. Kahi S, Cozon GJN, Peyron F. Early detection of cellular immunity in congenitally Toxoplasma gondii-infected children. Pediatr Infect Dis J. 1999;18:846-847.
21. Maino VC, Suni MA, Ruitenberg JJ. Rapid flow cytometric method for measuring lymphocyte subset activation. Cytometry. 1995;230:127-133.
22. Wilson CB, Desmots GD, Couvreur J, Remington JS. Lymphocyte transformation in the diagnosis of congenital toxoplasma infection. New Engl J Med. 1980;302:785-788.
23. Avanzini MA, Belloni C, Soncini R, et al. Increment of recombinant hepatitis B surface antigen-specific T-cell precursors after revaccination of slow responder children. Vaccine. 2001;19:2819-2824.
24. Palermo B, Garbelli S, Mantovani S, et al. Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligo. Eur J Immunol. 2005;35:3153-3162.
25. Jaisson-Hot I, Wallon M, Al-Kurdi M, et al. Toxoplasmose congenitale: negativation transitoire de la serologie. Presse Med. 2000;30:1001-1004.
26. McLeodR, MackDG, BoyerK, etal. Phenotypes and functions of lymphocytes in congenital toxoplasmosis. J Lab Clin Med. 1990;116:623-635.
27. McLeod R, Beem MO, Estes RG. Lymphocyte anergy specific to Toxoplasma gondiiantigens in a baby with congenital toxoplasmosis. J Clin Lab Immunol. 1985;17:149-153.